Successful Radiofrequency Catheter Ablation of Left Ventricular Tachycardia Following Surgical Correction of Tetralogy of Fallot

Fukuhara, Hitoo; Nakamura, Yoshihide; Tasato, Hiroshi; Tanihira, Yuko; Baba, Kiyoshi; Nakata, Youhei

doi:10.1111/j.1540-8159.2000.tb00979.x

Cited by 10 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Several studies have documented the feasibility of using catheter ablation to treat MMVT in patients with CHD [288][289][290][291]. Success rates in these studies have ranged from $ 60% to 490% case series of 11-20 patients and in one case ablation has been proposed in conjunction with use of Class III antiarrhythmic agents [292].…”

Section: Management Of Ventricular Tachycardia and Premature Ventricumentioning

confidence: 99%

EHRA/HRS/APHRS expert consensus on ventricular arrhythmias

Pedersen¹,

Kay²,

Kalman³

et al. 2014

Journal of Arrhythmia

View full text Add to dashboard Cite

Section: Management Of Ventricular Tachycardia and Premature Ventricumentioning

confidence: 99%

EHRA/HRS/APHRS expert consensus on ventricular arrhythmias

Pedersen¹,

Kay²,

Kalman³

et al. 2014

Journal of Arrhythmia

View full text Add to dashboard Cite

“…Several other diseases, i.e., congenital heart disease like tetralogy of Fallot even late after repair, valvular heart disease, sarcoidosis, Chagas' disease and different others, might be associated with recurrent monomorphic VT [15,25,31,35,37,38]. In most cases, the underlying arrhythmia mechanism is reentry somehow related to myocardial scarring like in coronary artery disease.…”

Section: Ablation Of Ventricular Tachycardia Of Other Causesmentioning

confidence: 99%

Electroanatomic Mapping of the Endocardium

Wetzel

Hindricks

Dorszewski

et al. 2003

Herz

View full text Add to dashboard Cite

The electroanatomic mapping system Carto((R)) with its combination of anatomic and electrophysiologic information has substantially improved our understanding of arrhythmia mechanisms and substrates in patients with ventricular tachycardia (VT) and structural heart disease. Identification of the individual arrhythmogenic substrate and successful ablation guided by the combination of sinus rhythm voltage mapping and conventional electrophysiologic techniques like pace and activation/entrainment mapping are best described for patients with recurrent VT in remote myocardial infarction. In about 75-90% of the patients, the target VT can be ablated with acute success and the patients remain free of any VT recurrence in up to 75%. First results of electroanatomically guided ablation in patients with arrhythmogenic right ventricular dysplasia are promising. Data on ablation of VT in other structural heart diseases are very limited, since the arrhythmogenic substrate is very diffuse, e. g., in dilated cardiomyopathy, or there are only small patient numbers, e. g., for cardiac sarcoidosis or monomorphic VT after repair of congenital heart disease. In this article, the current status of electroanatomically guided endocardial mapping and ablation of VT in patients with structural heart disease is described.

show abstract

“…Ventrikuläre Tachykardien Bei Patienten mit einem Vitium betreffen die meisten Einzelberichte über erfolgreiche Ablationen Patienten nach Korrekturoperation eines M. Fallot [3,8,12,29]. Berichte über Patienten mit anderen Vitien sind selten, in einer Zusammenstellung mit kleiner Fallzahl (n=16; Fallot: n=9, VSD: n=4, Pulmonalstenose: n=2, TGA+VSD: n=1), konnte bei 94% der Patienten die ventrikuläre Tachykardie erfolgreich beseitigt werden.…”

Section: Indikationen Und Ergebnisseunclassified